Public records · research cutoff 30 August 2026
A navigable account of the Bulgarian fertilizer company: what is verified, what is merely supported, what the company claims, what conflicts, and what remains unknown.
Evidence-weighted verdict
Atlas has genuine Bulgarian intellectual property, qualified scientific founders, valid product registrations and rising filed sales. Its most distinctive asset is a patent for turning sewage-treatment sludge into plant biostimulant. Its current agricultural products, however, are registered as molasses/leonardite formulations. Public evidence does not show that those products use the sludge patent, and independent evidence for their broad performance claims is still thin.
The essential public-record facts, separated from forecasts, awards, municipal logos and performance language.
The central analytical mistake is to tell Atlas’s history as one uninterrupted patented-product success story.
Chapter one · 2016–2023
Academic wastewater-sludge work led to a startup, prototype, patent filings, waste authorization and a landscaping product family. The company later acknowledged that Bulgarian rules did not provide a route to register the processed-sludge product for agriculture.
Verified history
Chapter two · 2024 onward
Atlas Terra, Nitro and Amino entered the agricultural register. Their signed orders list molasses, leonardite and free amino acids—not sewage sludge. This is best understood as a commercial and formulation pivot.
Verified pivot
The unresolved bridge: Atlas markets the current line as developed through its patented technology, but no public claim chart, manufacturing record or technical explanation connects a sludge-conversion patent to the listed molasses/leonardite formulations.
Each section starts with the strongest available fact and then shows conflicts, limitations and the company’s own framing.
History
From doctoral research and the 2019 incorporation through the regulatory dead end, pivot and 2026 ownership change.
Open the timeline →People & control
Legal founders versus narrative founders, scientific credentials, ownership changes and the unresolved Nikolay identities.
Meet the people →Products
Official compositions and doses for Terra, Nitro and Amino, plus every material conflict with current web copy.
Inspect the products →Business
Filed financials, funding, distributor structure, pricing, municipal relationships and market-scale scenarios.
Read the business record →Evidence
Patent scope, the rose study, disclosed and undisclosed conflicts, EIT Test Farms and missing validation.
Evaluate the evidence →Marketing
The pitch is preserved on its own terms, followed by a line-by-line factual status and the evidence required to support it.
Compare claim with fact →The site avoids turning an absence into a fact. “Unknown” means the information requires company disclosure, unpublished regulator files or a future filing.
Statutory records outrank company copy. Signed product orders outrank stale web pages. Selection for a program is not treated as a successful result. Municipal use is not turned into revenue without a contract.
Directly supported by a deed, filed account, patent record, permit, signed order or official statistic.
Confirmed activity or relationship, but not independently audited or commercially quantified.
What Atlas or its distributor says. Preserved as attribution, never promoted into fact without evidence.
Not responsibly answerable from public sources. Converted into a diligence question instead of a guess.